Article Details

Adagene Announces Clinical Advancement for ADG116

Retrieved on: 2021-03-29 11:37:30

Tags for this article:

Click the tags to see associated articles and topics

Adagene Announces Clinical Advancement for ADG116. View article details on hiswai:

Excerpt

ADG116 is a fully human, anti-CTLA-4 monoclonal antibody (mAb), ... half-life of ADG116 was within the normal range of IgG1 based antibodies.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo